Envoy Medical, Inc. has announced a 1-for-10 reverse stock split of its Class A common stock, effective October 26, 2026. This strategic move is intended to improve the company's stock price and enhance its market perception. The reverse stock split will allow each ten shares of the company's stock to be combined into one share, a common practice among companies looking to stabilize their stock values in the market.
The decision comes after stockholders approved the amendment at a special meeting held on October 12, 2026. The board of directors had the authority to determine the ratio of the reverse stock split within a specified range, ultimately deciding on the 1-for-10 ratio. This change will not affect the par value of the stock, which remains at $0.0001 per share.
As of the effective date, the common stock began trading on a post-split basis under the same ticker symbol, "COCH," on the Nasdaq Capital Market. The company has assured stockholders that no fractional shares will be issued as a result of the reverse stock split. Instead, stockholders entitled to receive a fractional share will receive a cash payment in lieu thereof.
Envoy Medical, based in White Bear Lake, Minnesota, operates in the orthopedic, prosthetic, and surgical appliances and supplies industry. The company aims to position itself favorably in a competitive market where similar strategies may be adopted by other firms facing stock price challenges.
Equiniti, the company's transfer agent, will facilitate the reverse stock split and provide stockholders with transaction statements reflecting their new shareholdings. Those holding shares through brokers or banks will have their positions adjusted automatically without needing to take any action.
The filing, which can be accessed under accession number 0001213900-26-112720, provides further details on this significant corporate action.